Leukemia inhibitory factor receptors and fusion proteins
US5420247A · kind A · utility
12Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 1993 |
| Grant date | May 30, 1995 |
| Priority date | — |
| Expiry date | Sep 10, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Leukemia inhibitory factor receptor (LIF-R) proteins, DNAs and expression vectors encoding LIF-R, and processes for producing LIF-R as products of recombinant cell culture, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.